Urocortin is the principal ligand for the corticotrophin-releasing factor binding protein in the ovine brain with no evidence for a sauvagine-like peptide

被引:12
|
作者
Baigent, SM [1 ]
Lowry, PJ [1 ]
机构
[1] Univ Reading, Sch Anim & Microbial Sci, Reading RG6 6AJ, Berks, England
关键词
D O I
10.1677/jme.0.0240053
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To purify novel ligands for the corticotrophin-releasing factor binding protein (CRF-BP) from ovine brain, whole brain was homogenised in methanol and the supernatant extracted on Sep-pak Cls cartridges followed by a preliminary HPLC step. Three peaks of ovine CRF-BP ligand activity were detected in the HPLC fractions, the first two of which were also detected by a specific corticotrophin-releasing factor two-site immunoradiometric assay, the third peak being detected by a human CRF-BP ligand assay, which will not detect ovine CRF. Human CRF-BP ligand-containing fractions were further purified by affinity chromatography on a human recombinant CRF-BP column with two additional HPLC steps. The human CRF-BP ligand was found to: (a) possess a molecular mass of 4707 Daltons, (b) have an N-terminal amino acid sequence (5 residues) identical to rat urocortin, (c) be detected by a specific urocortin radioimmunoassay, (d) have high affinity for both the human and ovine CRF-BPs and (e) be present in many regions of the ovine brain. Additionally, a 300 bp cDNA fragment sharing 83% homology with the rat urocortin gene was cloned from ovine brain, the product of which was predicted to have an identical amino acid sequence to that of rat urocortin. These pieces of information confirmed the identity of the human CRF-BP ligand as an ovine urocortin. The specially developed CRF-BP ligand assays showed that the rank orders of affinity of the CRF family members fur human CRF-BP were: carp urotensin-1>>human CRF=rat/ovine urocortin>human urocortin>>frog sauvagine>>ovine CRF, and those for the ovine CRF-BP were: carp urotensin-1>human CRF = rat/ovine urocortin>human urocortin>frog sauvagine>>ovine CRF. This study describes a successful technique for the purification and detection of peptide ligands for the CRF-BP. We conclude that urocortin is the principal ligand for the CRF-BP in ovine brain and we could find no evidence for a centrally located mammalian sauvagine-like peptide.
引用
收藏
页码:53 / 63
页数:11
相关论文
共 30 条
  • [21] Urocortin interaction with corticotropin-releasing factor(CRF) binding protein (CRF-BP): A novel mechanism for elevating 'free' CRF levels in human brain
    Behan, DP
    Khongsaly, O
    Ling, N
    DeSouza, EB
    BRAIN RESEARCH, 1996, 725 (02) : 263 - 267
  • [22] The RNA-binding protein HUD co-localizes with choline acetyl transferase (pChAT) and corticotrophin-releasing factor (CRF)-Receptor type I (CRF-R1) in ovine fetal disatal colon neurons:: Mechanisms of in utero meconium passage.
    Lakshmanan, Jayaraman
    Richard, John D.
    Liu, Guo L.
    Sugano, Sharon K.
    Balbuena, Octavio
    Ross, Michael G.
    REPRODUCTIVE SCIENCES, 2008, 15 (02) : 235A - 235A
  • [23] Regional rat brain distribution of [76Br]MJL-1-109-2, a non-peptide corticotrophin-releasing hormone type 1 receptor (CRHR1) ligand, using in vitro autoradiography
    Jagoda, EM
    Contoreggi, C
    Lee, MJ
    Kao, CK
    Szajek, LP
    Gold, PW
    Chrousos, GP
    Jacobson, AE
    Rice, KC
    Eckelman, WC
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 224P - 224P
  • [24] Cocaine- and amphetamine-regulated transcript, glucagon-like peptide-1 and corticotrophin releasing factor inhibit feeding via agouti-related protein independent pathways in the rat
    Edwards, CMB
    Abbott, CR
    Sunter, D
    Kim, MS
    Dakin, CL
    Murphy, KG
    Abusnana, S
    Taheri, S
    Rossi, M
    Bloom, SR
    BRAIN RESEARCH, 2000, 866 (1-2) : 128 - 134
  • [25] Binding of Fluorinated Phenylalanine α-Factor Analogues to Ste2p: Evidence for a Cation-π Binding Interaction between a Peptide Ligand and Its Cognate G Protein-Coupled Receptor
    Tantry, Subramanyam
    Ding, Fa-Xiang
    Dumont, Mark
    Becker, Jeffrey M.
    Naider, Fred
    BIOCHEMISTRY, 2010, 49 (24) : 5007 - 5015
  • [26] CHARACTERIZATION OF INSULIN-LIKE GROWTH FACTOR-II BINDING-SITES IN THE RAT-BRAIN BY QUANTITATIVE AUTORADIOGRAPHY - EVIDENCE FOR AN IGF-II BINDING-PROTEIN
    BASKIN, DG
    BOHANNON, NJ
    KING, MG
    WIMPY, TH
    ROSENFELD, RG
    NEUROSCIENCE RESEARCH COMMUNICATIONS, 1990, 7 (01) : 53 - 60
  • [27] REGULATION OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-4 IN HUMAN ENDOMETRIAL STROMAL CELL-CULTURES - EVIDENCE FOR LIGAND-INDUCED PROTEOLYSIS
    IRWIN, JC
    DSUPIN, BA
    GIUDICE, LC
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (02): : 619 - 626
  • [28] Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor:: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity
    Hoare, SRJ
    Sullivan, SK
    Fan, J
    Khongsaly, K
    Grigoriadis, DE
    PEPTIDES, 2005, 26 (03) : 457 - 470
  • [29] Novel Relationships of Age, Visceral Adiposity, Insulin-Like Growth Factor (IGF)-I and IGF Binding Protein Concentrations to Growth Hormone (GH) Releasing-Hormone and GH Releasing-Peptide Efficacies in Men during Experimental Hypogonadal Clamp
    Veldhuis, Johannes D.
    Keenan, Daniel M.
    Bailey, Joy N.
    Adeniji, Adebordurin M.
    Miles, John M.
    Bowers, Cyril Y.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (06): : 2137 - 2143
  • [30] Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women
    Bowers, CY
    Granda, R
    Mohan, S
    Kuipers, J
    Baylink, D
    Veldhuis, JD
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (05): : 2290 - 2300